The Top Line
Fierce Life Sciences
Add to My Podcasts
Episodes
About
Reviews
Promote
Inside the sterile fill capacity crunch (Sponsored)
9 minutes
Posted Feb 23, 2026 at 2:00 pm.
0:00
9:41
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
GRAM’s CEO on isolators, re-shoring and rising demand in sterile fill manufacturing.
Previous
Trump's tariff threats, measured by manufacturing
Next
Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
← See all 100 episodes of The Top Line